TRPC6 and focal segmental glomerulosclerosis: Systematic analysis of TRPC6-related mutations showed that loss-of-function (LOF) of TRPC6 has the potential to induce disease [32], which may cause FSGS earlier than in GOF-type TRPC6 patients by interacting with actin cytoskeleton rearrangement during podocyte development [33].